Microsoft Foundry is expanding to support scientific AI workloads, particularly in healthcare and life sciences. The new GigaTIME model, now available in Foundry, analyzes standard pathology slides to provide deeper biological insights. GigaTIME translates routine hematoxylin and eosin slides into spatially resolved protein activation maps, offering insights into tumor microenvironments. This model enables population-scale analysis, biomarker discovery, and patient stratification across cancer types. Researchers can leverage GigaTIME to retrospectively analyze clinical trial data, assess tumor-immune interactions, and understand immune system structure. Users can initially explore GigaTIME in Foundry Labs to understand how it works and can access more advanced workflows via GitHub. GigaTIME facilitates easy exploration and deployment within Microsoft Foundry's model catalog for diverse research applications. This technology supports a new class of scientific AI, emphasizing multimodal, domain-specific, and spatial outputs. Researchers are encouraged to explore GigaTIME and its capabilities through the provided resources for improved scientific discovery. The model has the potential to transform data into insights. Microsoft is excited about the future possibilities for this research.
techcommunity.microsoft.com
techcommunity.microsoft.com
